Vistagen Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Dec 2025Filed 12/02/2026 | Sep 2025Filed 12/02/2026 | Jun 2025Filed 14/08/2026 | Dec 2024Filed 12/02/2026 | Sep 2024Filed 12/02/2026 | Jun 2024Filed 12/02/2026 | Dec 2023Filed 13/02/2025 |
|---|---|---|---|---|---|---|---|---|
| $1.5 | $0.3 | $0.3 | $0.2 | $0.2 | $0.2 | $0.1 | $0.4 | |
| −$13 | −$19 | −$19 | −$15 | −$14 | −$13 | −$11 | −$6.4 | |
| −$0.30 | −$0.45 | −$0.54 | −$0.47 | −$0.46 | −$0.42 | −$0.35 | −$0.22 | |
| 43 | 42 | 36 | 32 | 31 | 31 | 31 | 29 |
Trend